United States · FDA National Drug Code directory
Gemfibrozil
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-821_2d16c495-7862-4ffc-a9ee-a1c816af5ae5
- Product NDC
- 69097-821
- Form
- TABLET
- Composition / generic term
- Gemfibrozil
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161013
- Source listing expiry
- 20261231
Source-listed ingredients
- GEMFIBROZIL — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET in 1 BOTTLE (69097-821-03) · 69097-821-03
- 100 TABLET in 1 BOTTLE (69097-821-07) · 69097-821-07
- 500 TABLET in 1 BOTTLE (69097-821-12) · 69097-821-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →